PS7:129 Synergetic b-cell immunomodulation with rituximab and belimumab combination treatment in severe, refractory sle

T Kraaij; SWA Kamerling; ENM de Rooij; PLA van Daele; OW Bredewold; JA Bakker; IM Bajema; HU Scherer; REM Toes; TWJ Huizinga; TJ Rabelink; C van Kooten; YKO Teng

doi:10.1136/lupus-2018-abstract.172

Article info

PDF

Poster session 7: New drugs and trageted therapy

PS7:129 Synergetic b-cell immunomodulation with rituximab and belimumab combination treatment in severe, refractory sle

Free

Authors

T Kraaij 1Department of Nephrology, LUMC, Leiden, The Netherlands PubMed articles Google scholar articles
SWA Kamerling 1Department of Nephrology, LUMC, Leiden, The Netherlands PubMed articles Google scholar articles
ENM de Rooij 1Department of Nephrology, LUMC, Leiden, The Netherlands PubMed articles Google scholar articles
PLA van Daele 2Department of Clinical Immunology, Erasmus MC, Rotterdam, The Netherlands PubMed articles Google scholar articles
OW Bredewold 1Department of Nephrology, LUMC, Leiden, The Netherlands PubMed articles Google scholar articles
JA Bakker 3Department of Clinical Chemistry and Laboratory Medicine, LUMC, Leiden, The Netherlands PubMed articles Google scholar articles
IM Bajema 4Department of Pathology, LUMC, Leiden, The Netherlands PubMed articles Google scholar articles
HU Scherer 5Department of Rheumatology, LUMC, Leiden, The Netherlands PubMed articles Google scholar articles
REM Toes 5Department of Rheumatology, LUMC, Leiden, The Netherlands PubMed articles Google scholar articles
TWJ Huizinga 5Department of Rheumatology, LUMC, Leiden, The Netherlands PubMed articles Google scholar articles
TJ Rabelink 1Department of Nephrology, LUMC, Leiden, The Netherlands PubMed articles Google scholar articles
C van Kooten 1Department of Nephrology, LUMC, Leiden, The Netherlands PubMed articles Google scholar articles
YKO Teng 1Department of Nephrology, LUMC, Leiden, The Netherlands PubMed articles Google scholar articles

Citation

Kraaij T, Kamerling S, de Rooij E, et al

PS7:129 Synergetic b-cell immunomodulation with rituximab and belimumab combination treatment in severe, refractory sle

Lupus Science & Medicine 2018;5:doi: 10.1136/lupus-2018-abstract.172

Publication history

First published March 21, 2018.

Online issue publication

March 21, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password